Deep Dive: R&D

While we should be hesitant in saying the COVID-19 pandemic will be over soon (I think we were all saying that last spring, after all) there is at least some light at the end of the tunnel, thanks primarily to pharma’s historic R&D efforts in new drugs and vaccines.

It seems like a good time, then, for the industry to start doing what it was unable to do at the outset of COVID-19 – planning for the future to ensure the R&D landscape can remain as strong as it is now.

As we find out in this issue, achieving this will require the industry to harness agile working, digitalisation and new, collaborative infrastructures.

Luckily, these are all things that pharma has already embraced during the pandemic, as we see in interviews with LEO Pharma’s new R&D lead Jörg Möller and data specialist Dr Maria Chatzou Dunford, as well as experts from the National Institute for Health Research (NIHR), Advanced Clinical and Bruntwood SciTech, among many others.

We also shine a light on some of the smaller life science companies aiding the COVID response, and with commentary from NexGen Healthcare Communications’ Emma Sutcliffe look at initiatives and digital innovations that are helping to combat the ‘invisibility’ of rare disease patients.

I hope you’re all staying safe in these unpredictable times!

George

George Underwood editor, Deep Dive

For the best page-viewing experience, make sure you have your browser at full-screen size. Use the left/right arrow buttons to scroll through the pages or click on the menu icon bottom centre to navigate. You can also share the articles on social media by clicking the icon bottom left at the base of the main navigation or at the end of each article.

Next issue: Market Access
Plus:
• Listening to patients
• Digital health reimbursement
• The NICE methods review

 

Catch up on recent issues:

Patients & Partnerships – December 2020
Digital Health Innovation – October 2020
Communications – September 2020
The Future of Oncology – July 2020

Video
Share

Your name

Your e-mail

Name receiver

E-mail address receiver

Your message

Send

Share

E-mail

Facebook

Twitter

LinkedIn

Contact

Send